Beyond Generics: Why Biologics and Advanced Therapeutics Are India’s Next Pharma Frontier
For decades, India’s life sciences identity has rested on a formidable but ultimately derivative foundation—generics, contract manufacturing, and vaccine production delivered at a scale and cost efficiency that the world has come to rely upon. That foundation remains commercially indispensable. What is shifting, with gathering momentum, is the ambition layered above it. Biologics and advanced […]










